NIH-funded research Career grant

Understanding how single-cell genetics relate to type 2 diabetes in young people

Official title: Mapping Integrated Single-Cell Chromatin Accessibility with the Single-Cell Transcriptional Landscape in Pediatric Type 2 Diabetes

Funded at Emory University · NIH-11082215 · Data updated 2026-11-12

This study is looking at the genes and molecules that might cause type 2 diabetes in young people under 21, with the goal of finding new ways to prevent and treat the condition by understanding how different immune cells play a role.

More Diabetes research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startMay 1, 2023
Project endApril 30, 2027
Funding year2025
Award (this year)$151,902
NIH project number5K01DK133669-03
Project IDNIH-11082215 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are youth under 21 years old who are at risk for or diagnosed with type 2 diabetes.

Less likely to help

Patients over the age of 21 or those without type 2 diabetes may not benefit from this research.

What this research studies

This research investigates the genetic and molecular factors contributing to type 2 diabetes (T2D) in individuals under 21 years of age. By using advanced techniques to analyze single-cell chromatin accessibility and transcription factors, the study aims to identify new targets for prevention and treatment of T2D. It combines laboratory work with bioinformatics, including machine learning, to integrate various data types and classify different T2D phenotypes. The research also focuses on understanding the roles of different immune cell types in the disease process, which could lead to more personalized treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to new prevention and treatment strategies for type 2 diabetes in young individuals.

How similar studies have gone: Previous research has shown promise in using single-cell techniques to understand complex diseases, suggesting potential success for this approach.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Staimez, Lisa Rachel — Emory University
  • Study coordinator: Staimez, Lisa Rachel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.